GlassScriptPhysician profile
Kecia M Kirk
NPI 1407957632
$8,187.24
in general payments reported to CMS, 2019-2025
54 companies · $635 in 2025
The $635 reported for 2025 was more than what 78% of Family Medicine providers received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $979 · 2020: $781 · 2021: $1,297 · 2022: $1,734 · 2023: $1,405 · 2024: $1,357 · 2025: $635.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,396.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,396.02 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,160.99 | 2021-2025 | |
| Amgen INC. | $718.49 | 2019-2025 | Evenity, Prolia, Repatha |
| Novo Nordisk INC | $629.99 | 2019-2025 | Ozempic, Saxenda, Wegovy |
| Lilly USA, LLC | $609.29 | 2019-2025 | Mounjaro, Zepbound, Jardiance |
| Astrazeneca Pharmaceuticals LP | $603.44 | 2019-2025 | Farxiga, Breztri, Airsupra |
| Boehringer Ingelheim Pharmaceuticals, INC. | $458.92 | 2021-2025 | Jardiance, Ofev |
| Pfizer INC. | $335.16 | 2019-2025 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $283.75 | 2019-2024 | Xifaxan, Trulance |
| Bayer Healthcare Pharmaceuticals INC. | $277.56 | 2022-2025 | |
| Abbott Laboratories | $225.07 | 2021-2024 | Freestyle Libre, Freestyle Libre 3 |
| Takeda Pharmaceuticals U.S.A., INC. | $211.33 | 2019-2025 | Trintellix |
| Otsuka America Pharmaceutical, INC. | $190.87 | 2022-2024 | Rexulti |
| Sanofi-Aventis U.S. LLC | $185.29 | 2019-2022 | |
| Janssen Pharmaceuticals, INC | $160.41 | 2019-2021 | |
| Amarin Pharma, INC. | $147.11 | 2019-2022 |
Show all 54 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kecia Kirk listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.